For four generations, Rome’s Angelini family has built a $2.5 billion operation with drugs for depression and epilepsy in Europe. Now it’s bought its way into the U.S. market.
In this week’s edition of InnovationRx, we look at Summa Health’s first tech bets, the healthcare leaders on Forbes Veteran 250 list, BioMarin’s acquisition of an early-stage bone disease therapy, and more.
Despite racking up more than $2 billion in losses while sticking to a do-it-yourself strategy, buy-now, pay-later pioneer Affirm is finally profitable—and worth $25 billion.
Chairman and CEO Wang Xingxing’s fortune surged nearly sevenfold to $16 billion as investors bet on China’s leading humanoid robot maker.
Despite billions in revenues, most influencers and their popular channels carry too much “key-person” risk for institutional investors. This UK firm has figured out how to turn viral videos into evergreen products.
From wildlife encounters to trail etiquette, discover how to avoid becoming a “touron” during your next national park adventure.
This week’s Current Climate newsletter also looks at big funds flowing into long-duration battery makers and the impact of a big proposed cut to NOAA’s budget.
Elon Musk’s DOGE gutted staffing and budgets at NOAA and the National Weather Service early last year. It left fishing fleets, farmers and insurers exposed to the fallout
A TikTok Shop sponsored survey finds it’s the top way consumers discover new products. But then they often buy elsewhere, such as on Amazon, say e-commerce pros.
Artificial intelligence is reshaping the workplace—but not always in the ways people think. What does that mean for your career? Join Forbes expert journalists and leading workplace experts Thursday, August 27th at 12pm ET for a live conversation with …